American Society of Clinical Oncology confers highest honor

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Related Keywords

United States , Hong Kong , Suzhou , Jiangsu , China , Texas , Rockville , Illinois , Chicago , Australia , Houston , American , Hagopm Kantarjian , Ascentage Pharma , Dajun Yang , Davida Karnofsky , Dana Farber Cancer Institute , Md Anderson Cancer Center , American Society Of Clinical Oncology , Samsung Distinguished University , Department Of Leukemia , Rice Baker Institute Houston , Society Of Hematologic Oncology , University Of Texas Md Anderson Cancer Center , Astrazeneca , Major National , National Reimbursement Drug List , China National Medical Products Administration , Drug Administration , Clinical Advisory Board , Prof Hagop , Memorial Award , American Society , Clinical Oncology , Annual Meeting , Samsung Distinguished University Chair , Cancer Medicine , Prof Kantarjian , Prof Peter , Hematologic Oncology , Rice Baker Institute , Affordable Care Act , Ascentage Pharma Clinical Advisory Board , Main Board , Stock Exchange , Hong Kong Limited , Major National Rd Projects , Major New Drug Projects , New Drug Incubator , Innovative Drug Programs , Major Project , Priority Review Designations , Breakthrough Therapy Designations , Drug Evaluation , Reimbursement Drug List , Orphan Drug Designation , Fast Track Designation , Orphan Designation , Cancer Center , Mayo Clinic ,